Received Mar 10, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
nerve pain; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of nerve pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles (in 2016). On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced nerve pain (Verbatim: nerve pain). The patient was treated with ketamine. The outcome of the nerve pain was resolving. It was unknown if the reporter considered the nerve pain to be related to Shingles vaccine. It was unknown if the company considered the nerve pain to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 03-MAR-2026 This case was reported by a patient via interactive digital media. The patient had a severe case on back in 2016 that remained severe and caused nerve pain. The physician prescribed a topical ketamine cream to be applied two to three times a day. It gave some pain relief. The batch number was not provided and unable to contact the reporter.
Medical History/Concurrent Conditions: Shingles (in 2016)